WHITTIER TRUST CO OF NEVADA INC
BankPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1263548
RENO, NV
Position in ALNY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$55,389
-$17,071 QoQ
Shares Held
184
-16.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#624
of 786 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WHITTIER TRUST CO OF NEVADA INC holds $867,253 across 28 Biotechnology names. ALNY ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
546 | $271,214 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
10,200 | $152,388 | |
| 3 | ANRO |
Alto Neuroscience, Inc.
|
2,482 | $65,499 | |
| 4 | TECH |
BIO-TECHNE Corp
|
830 | $58,639 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
184 | $55,389 | |
| 6 | CGON |
CG Oncology, Inc.
|
666 | $47,319 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
68 | $42,400 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
375 | $29,351 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,389 | 184 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $72,460 | 219 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $32,607 | 82 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $52,440 | 115 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $16,956 | 52 | Shares | Sole | 2025-07-30 | |
| No filing history on record for this holder in this stock. | ||||||